Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guoshu Bi

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
JAMA Oncology|December 28, 2023
Nontumor Cells in Tumor Samples Bias Expression-Based ModelsJiaqi Liang, Guoshu Bi, Cheng Zhan
Annals of Translational Medicine|September 21, 2020
Multinomial and ordinal Logistic regression analyses with multi-categorical variables using RJiaqi Liang, Guoshu Bi, Cheng Zhan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 21, 2022
Propensity Score Matching for Bias Reduction in Genomic ProfilingGuoshu Bi, Jiaqi Liang, Guangyao Shan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 23, 2021
Could T3<sub>Satell</sub> Tumors Be Considered Reclassified as T2b?Ming Li, Jiaqi Liang, Guoshu Bi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 24, 2021
Some Thoughts Concerning the Mutational Background of Cell Lines and Heterogeneity of Bulk TumorGuoshu Bi, Jiaqi Liang, Guangyao Shan, et al.
Annals of Translational Medicine|March 17, 2020
A nomogram with enhanced function facilitated by nomogramEx and nomogramFormulaGuoshu Bi, Runmei Li, Jiaqi Liang, et al.
Journal of Immunology Research|May 2, 2022
Tumor-Associated Regulatory T Cells in Non-Small-Cell Lung Cancer: Current Advances and Future PerspectivesJiaqi Liang, Guoshu Bi, Guangyao Shan, et al.
Frontiers in Oncology|June 16, 2020
Development and Validation of a 12-Gene Immune Relevant Prognostic Signature for Lung Adenocarcinoma Through Machine Learning StrategiesLiang Xue, Guoshu Bi, Cheng Zhan, et al.
Annals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia|October 8, 2019
The Effect of Diabetes Mellitus on Prognosis of Patients with Non-Small-Cell Lung Cancer: A Systematic Review and Meta-AnalysisGuoshu Bi, Guangyu Yao, Yunyi Bian, et al.
Cancer Cell International|March 24, 2021
Knockdown of GTF2E2 inhibits the growth and progression of lung adenocarcinoma via RPS4X in vitro and in vivoGuoshu Bi, Donglin Zhu, Yunyi Bian, et al.
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
JAMA Oncology|December 28, 2023
Nontumor Cells in Tumor Samples Bias Expression-Based ModelsJiaqi Liang, Guoshu Bi, Cheng Zhan
Annals of Translational Medicine|September 21, 2020
Multinomial and ordinal Logistic regression analyses with multi-categorical variables using RJiaqi Liang, Guoshu Bi, Cheng Zhan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 21, 2022
Propensity Score Matching for Bias Reduction in Genomic ProfilingGuoshu Bi, Jiaqi Liang, Guangyao Shan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 23, 2021
Could T3<sub>Satell</sub> Tumors Be Considered Reclassified as T2b?Ming Li, Jiaqi Liang, Guoshu Bi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 24, 2021
Some Thoughts Concerning the Mutational Background of Cell Lines and Heterogeneity of Bulk TumorGuoshu Bi, Jiaqi Liang, Guangyao Shan, et al.
Annals of Translational Medicine|March 17, 2020
A nomogram with enhanced function facilitated by nomogramEx and nomogramFormulaGuoshu Bi, Runmei Li, Jiaqi Liang, et al.
Journal of Immunology Research|May 2, 2022
Tumor-Associated Regulatory T Cells in Non-Small-Cell Lung Cancer: Current Advances and Future PerspectivesJiaqi Liang, Guoshu Bi, Guangyao Shan, et al.
Frontiers in Oncology|June 16, 2020
Development and Validation of a 12-Gene Immune Relevant Prognostic Signature for Lung Adenocarcinoma Through Machine Learning StrategiesLiang Xue, Guoshu Bi, Cheng Zhan, et al.
Annals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia|October 8, 2019
The Effect of Diabetes Mellitus on Prognosis of Patients with Non-Small-Cell Lung Cancer: A Systematic Review and Meta-AnalysisGuoshu Bi, Guangyu Yao, Yunyi Bian, et al.
Cancer Cell International|March 24, 2021
Knockdown of GTF2E2 inhibits the growth and progression of lung adenocarcinoma via RPS4X in vitro and in vivoGuoshu Bi, Donglin Zhu, Yunyi Bian, et al.
Pageof 8